Maximilian Mastall

MD/PhD | Neurology resident | Neuro-oncology researcher 🧠 🔬

[Tobias W. @to123w]

Happy to present our newest work cross-comparing CAR T cells, CAR NK cells and CAR macrophages in a solid brain tumor environment. Thanks to Thomas Look and our amazing collaborators @r_sankowski César Nombela Arrieta @
@snijderlab @StevePascolo
https://t.co/vUePYUbBm5

[Jan-Michael Werner @Jan_M_Werner]

It was a great pleasure and privilege to be working with amazing colleagues in the #EANOyoungsters committee. @EANOassociation

[Maximilian Mastall @max5tall]

Very exciting new data and tools from @MILOLab2 presented at #eano2024 @EANOassociation

[Maximilian Mastall @max5tall]

Great start into #eano2024 with a fantastic session about innovative therapies for patients with brain tumors. Thanks for the overview! @EANOassociation

[Maximilian Mastall @max5tall]

@docbraincancer Thank you @docbraincancer! First I will finish my neurology residency training at the University Hospital Zurich!

[Maximilian Mastall @max5tall]

Last week I finally defended my PhD about CAR T cells against #glioblastoma. I am very grateful for everything I’ve learned during this time and for the continuous support of my PhD committee members and lab colleagues @usz_neurooncology. Excited for new challenges ahead!

[Maximilian Mastall @max5tall]

@NeuroOnco_USZ

[Editor - Neuro-Oncology Advances @EditorNeuro]

From a single-institution dataset of 200 adult patients diagnosed with #medulloblastoma during 1978–2017, those with recurrence were analyzed for clinical features, #treatment, and #outcome.

Learn more about the findings from this #ClinicalInvestigation:

https://t.co/kYQr2AWLZr

[EANO @EANOassociation]

#EANO is enjoying a fantastic #SNO2023 in Vancouver!
@NeuroOnc @EditorNeuro #NeuroOncology #btsm

[Neuro-Oncology_USZ @NeuroOnco_USZ]

We are having a great time at #SNO2023 @NeuroOnc and are grateful for the opportunity to present some of our ongoing research by posters and presentations. @to123w @AlidaSun7 @max5tall

[Maximilian Mastall @max5tall]

Grateful for receiving the Young Investigator Travel Scholarship and I am looking forward to the next 4 days!

[EANO @EANOassociation]

#EANO2023 Congrats to Maximillian Mastall for being awarded with the Young Investigator Travel Scholarship! We look forward to meeting young scientists and physicians in #NeuroOncology. Registration is still open https://t.co/By6VxD2znl #btsm @max5tall @OncoAlert @theIBTA

[Neuro-Oncology_USZ @NeuroOnco_USZ]

Happy to share our new manuscript @CCR_AACR! Hanna Meister & Thomas Look (@ThomasLook_) could show increased efficacy of mRNA based CAR T cells against glioblastoma after co-expression with pro-inflammatory cytokines. https://t.co/R1MqSftKq2

[Neuro-Oncology_USZ @NeuroOnco_USZ]

The Laboratory of Molecular Neuro-Oncology @Unispital_USZ is now online on twitter!
We are happy to announce that from now on we will use this channel to communicate our research and give insight into our daily work.

A general overview can be found @:
https://t.co/9xivApbLf0

[Tobias W. @to123w]

Excited to share our study on the proteomic landscapes of primary and recurrent glioblastoma https://t.co/pTInrUO84p

[Maximilian Mastall @max5tall]

Excited to share our findings on status epilepticus in patients with brain tumors.

[Brain @Brain1878]

Mastall et al. show that status epilepticus is associated with inferior survival in patients with malignant brain tumours, but not among patients with meningiomas, which are mostly benign. https://t.co/vwiQmF1nRf